**********
***** *** ***** ** ***** ** this ****'* *** ******** ***** ** Birmingham ***** ************ ** *** ***** ****** ******** in ****** ** ********* ** . *** **** ** ***, "***** & ******* ********* ********* ***** ************," began **** * ************ **** ******, Healy ****:
*** *** *************** *** *********** ****** the ****, *** *** ***** ********** respectful.
*****'* **** ******* ********* ********'* **** ** *** ***** ********* Party *** *** **** **** $* ******* in ****** ******** *** ********* **** secured ** ********. ** **** ***** about *** ****** **** ******* ******* Hikvision *** ***** ******** *** *** real-time ****** ****** ***** **** ****** *********** software .
Foreign ******* ******: *** ** ** ***?
** ***** ********* ***** ** ******* ******* ********* ****** recommendation ** *** ********* *** ***** ** *** **, ****** ***********, ******* incorrectly **** ***** ** **** * "tiny, ****** ******* ** *********" ** the ******. ****** **** ******* ***** of ****** *** ****** *** ** context.
*******, ***** ********* ************ **** *** ******** :
*** *********** *** **** ** *** only * ***** ******* ** *********/***** in *** ****** *** **** * was ****** ** *** ** *******, that *** ****** *** *** ******** about ****. * ********* ***, ****** I *** **** **-**** *** *** report **** *******, *** **** ** was *****. *** ****** **** ******* identified *****’* **** ** ********, ********* both ********* ******** *****, *** ******* stated **** ****** ** ******.
Atrocities ** ******** '*** *******'
**** *****'* ************ ******* ** ************* ********* ** ******** , ****** ***********, ******** *** **** the ***** ****** ****** *** ******** not ******* ** *****. ***** ********* that *** ***** ** *** *** is *** ********:
*** ******** **** ** ***** ************* law, *** ***** ***, *** ** any ****, ************** ** ******** ******* in *****.
****** ****, **** ** *** ******** atrocities *** '*****' ****** *** ***, it ** ** ********* ************ ********, though ********** *** **** ***** ********** regularly ****.
*************
***** ********* *** **** **** * focus ***************, *** ** *** **** ****** with ********* *** ***** ******** . ****** ****** **** ** * system ** *** ********-*********, ** ** "impregnable." ***** *********:
* *******-****** **** ******* ** ***********, that *************** **** ***** **** ** exploited ** ****** ***** ******, *** that ******** ******* ****** ** **** to **** ********* ** *** ****.
*** ****** ******** * *** ****** IPVM ********* *******'* ****** ******** *************** .
*** "*** ********-*********" ******** ** *********** but ** ******** ************ *********** ** more *** **** ***** **** ** be **** ** ****** ***** ***** surveillance ********. ******, ** ******** ********* *** **** ***** ******** showed , **** * *** ***** ***, massive ******* ** ***** ******* **** being ********* ** *** ********.
After *** ****
*** ********* ***, ********* *, ***** spoke **** ****** *** ***** ** he'd **** ** **** *** ********** comments, *** ****** ********. **** ********* Duggan's ******, *** ** ******* ** that ************ *** ********* ** **** report.
No ******* **** ******
**** ********* *** ****** ** *** for ******* ** **** *****. ****** responded ** ********* **** ** *** not **** ** ******* ** ** mentioned:
*******, *** ****** ****** ** *** interaction *** *** ************' ********* ** the ********, **** ****** **** ** be * ********** *****. **** ******* out ** ******* **** ** ***** not ******* ******** ******* ** ***** conversation *** **** ***, *** ***** focus ** *** ****** ***********. ****** again ******* ** *******.
Comments (34)
Undisclosed Integrator #1
** ** ********** **** *** ********** or ******* ***** **** ** ********* or ********* *** ** * ******* that ** *** ******, ******** ********** privacy, ** ***** ******. ***** ** cannot **** ***** ****** *******, ** would **** ***** ********** ** ********* use ** **** ******** *** ******* creation ** ******* **** *** ****** on *** ****** ** ***********. **** a ***** *********** ** *** ********* product ** ****** ** *** ******* of **** *** ****** **** ******** objectivity.
** ***** **** **** *** ** agreement **** ********** ***** *** ** used ** **** ***** ****** ** correctly *** *********** *********** ***** ********* them ** *********, **** *** *** what ******* **** *** **** *** to **** ********** *** ******* ********* structure.
**** **** ** ******* *** ******, and ***** ********** ******** *** ********** with ******** ** ****** ************, **** collection *** ** **** ** * way **** ******** ********** ******* *** Human ******. **** *** **** ***** to ********** **, ********** *** ************** of ********** ******** ** ****** ***** where *********** *********, ********, *** ******** have ** **** ** ** ****** place.
********** *** ***** *** ******, *** the *** *** *********** **** ****** structure *** ********** **** ******* ********** privacy ******* ***** ***** ** *** commercial ** ********* ********.
Create New Topic
Undisclosed #2
******* *** *********. *** * ************ with *** **** ****. ** *** like ****** ** * ***** ****. The ****** ** ****** **** ******* all *** ********** ** ** ******* logic *******.
Create New Topic
Undisclosed Distributor #3
*** *********, **** *** *** ****** fever ******* ****** **** **** **** where ******* **** **** *********
Create New Topic
Undisclosed #4
******* ****** ** *** ***** *****.. thanks.
Create New Topic
Undisclosed #6
Create New Topic
Undisclosed Manufacturer #7
******* **** ********……****** ****
Create New Topic
Undisclosed Integrator #1
*********** *** **** ******** *** ******* risks *** ******* *** ******* *** continues ** ****** ** ***** **** suggest ******* **** ********* *** ***************.
**** ** * ******** ******* ***** all.
** **** *** ***** ********* ******’* IT ********** ********* *** ** *** products ** **** ** ***** ******** chain ********* **** *********** ***-*** *******. It ** ** ********** ******* *** they **** ** *** *** **** way ** ****** *** ******* ***** not **** *** ********* ** **** on ***** *******.
******* *** ****** ** ****** *** expense ** ****** *** ********* ** its’ *** *******, ********, *** ******** provider.
Create New Topic
Undisclosed Manufacturer #8
**** **** ********* *** **** ** prison ** ********** ***??? *** **** do **** ************* ** ** *** are ***** ** **** ***** **** technology?
Create New Topic
Undisclosed Manufacturer #8
* *** *** **** ** *** company ** **** (** * *** on **** ***** ******** ***** **** topic *** **** **** ****), ** they ********* ********* **** **** ** last **** ?
*** *** ************** ******** **** *****. Is **** ******* ?
**** ********** * '*** **** *****China' ******
sorry *** ** ** ******* **** ** ******, **************
*** *** ******* **** ***** ****** and *** **** **** *** ***. As * **** *** **** ** have ** *****. *** *** ************ some *** **** ** ***** ***, your **** ....
**** * ********** ** **** **** time *** * ******* **** ** portal ***** ********** , *** *** changed **** ....
**** ** ** **** ***** ** this **********
*** **** ***** ***** ** ****, this **** *** **** *** *******.
** ** *** * **** ** at *** ********* :(
Create New Topic
Undisclosed Manufacturer #8
* *** **** ******** ... **** some ** **** ******* *** *** often *********.
*** ***** ********* "******" **** ******** **?
** ** ***, ***? **** ** discussion ... ** * ** *****?
** ***** ** ** **** *** that **** ******** ** ************** ******** made ** ***. ***. *** **** is ******
****** =prejudice, **************, or antagonism by an individual, community, or institution against * ****** ** ****** ** *** ***** ** ***** ********** ** * ********** ****** ** ****** *****
*** *** *** ****** **** ** can ***** *** :) * ** expressing ** **** ********** ** *******. You **** ********* ******* **** **. I ** *** **** ** ***** people *** ******* ****** *** "**** ever ******"
Create New Topic
Undisclosed #10
*** **** ********* *** ****** ** racism - *** ******** *** ******** presented **** ******** ******* **** *****.
****, *** ******** ******* ** **** if *** **** ***** ****
Create New Topic
Daniel Lewkovitz
Create New Topic
Nyasha Muzwidziwa
**** ***** **** **** *** *** supporters ******* ******* ******** ** ****** for *******. ******* ** *** ********. If *** ** *** **** ** buy *** ******* ****'* **** *** you. ***'* **** ******** **** ** your *****. * *** ** ******** conference ********* *** * *** ********* with ***** *** ******** ********
Create New Topic
Undisclosed Integrator #5
**** *** ***** ** ********* ****** "Chinese ********". **** **** ******* *** ethical ******** **** ******** ********* **** as ******* (* ** ***** *******), ADI (* ** *******) *** ********* (a ******* *******). ** ******* **** IPVM ** ********* **** "******* ** the *****" ** * ********** *****.
Create New Topic